Collaboration & Cooperation
AMMF is an active member of:
- Cholangiocarcinoma-UK
- NCRI (National Cancer Research Institute) Upper GI Cancers Hepatobiliary Group
- NCRI BTC Trial Management Group
- Global Cholangiocarcinoma Alliance
- European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- Cancer52
- ECPC Working Group on Rare Cancers
- The International Biliary Tract Cancer Collaborators Group
AMMF values its collaborative links with like-minded organisations and research centres across the UK, Europe and globally:
Organisations
- BASL (British Association for the Study of the Liver)
- The British Liver Trust
- British Society of Gastroenterology (BSG)
- Cancer Research UK
- Macmillan
- Rare Disease UK
- Rare Disease Europe (Eurordis)
- ESMO (European Society of Medical Oncology)
- European Cancer Patient Coalition (ECPC)
- The European Organisation for Research and Treatment of Cancer (EORTC)
- ERN (European Reference Networks)
- Cholangiocarcinoma Foundation of Thailand
- CASCAP
- Cholangiocarcinoma Australasia
- The Cholangiocarcinoma Foundation
- TargetCancer Foundation
- APiC (Associazione Pazienti Italiani di Colangiocarcinoma)
- ELPA (European Liver Patients’ Association)
Research Centres
- Imperial College London
- University College London
- The Institute of Hepatology London
- University of Birmingham
- University of Cambridge
- University of Edinburgh
- Institute of Genetics & Molecular Medicine (The University of Edinburgh)
- University of Nottingham
- University of East Anglia
- University of Manchester
- University of Liverpool
- University of Oxford
- University of Leeds
- Cardiff University
- Universities of Madrid, Navarra and Pamplona, Spain
- John Hopkins University, USA
For more information on the research AMMF is supporting, click here.
Corporate Supporters
We are very grateful for the support given by our generous corporate supporters, especially:
